Pulmonary tuberculosis in the adult in a low prevalence area: is the radiological presentation changing?

BACKGROUND AND OBJECTIVE: To investigate the efficacy, predictability, stability, and safety of photorefractive keratectomy (PRK) with scanning spot ablation for the treatment of myopia of less than -6.0 D. PATIENTS AND METHODS: Twenty eyes of 20 patients (11 men, 9 women) were enrolled into the study. The mean age was 26.2 +/- 5.4 years. Mean spherical equivalent myopia was -3.53 +/- 1.13 D, ranging from -2.25 to -6.00 D. Patients underwent excimer laser PRK for the treatment of myopia. Follow-up time was at least 24 months in all patients. RESULTS: Mean spherical equivalent refraction was +0.84 +/- 0.99 D at 1 month, +0.19 +/- 0.54 at 3 months, -0.01 +/- 0.53 at 12 months, and -0.13 +/- 0.50 at 24 months. There was a mean regression of 0.65 D between 1 and 3 months. At 24 months, 16 (80%) of the eyes remained within +0.50 D of emmetropia and 18 (90%) of the eyes remained within +/- 1.0 D of emmetropia. Nineteen (95%) of the eyes had uncorrected visual acuity of 20/40 or better. The mean corneal haze score was maximum at 3 months (0.88 +/- 0.22). There was no clinically significant corneal haze (greater than 2+). One eye (5%) lost 2 or more lines of best-corrected visual acuity. CONCLUSION: Excimer laser PRK with the scanning spot ablation technique is effective, predictable, stable, and safe for the treatment of myopia of less than -6.0 D.     

Photorefractive keratectomy for -1.25 to -25.00 diopters of myopia

BACKGROUND: We evaluated prospectively the efficacy, predictability, stability, and safety of photorefractive keratectomy (PRK) for myopia. METHODS: Three hundred sixty-nine eyes of 257 patients were treated with an Aesculap-Meditec MEL 60 excimer laser. Treated eyes were divided into 3 groups: low myopes (-1.25 to -6.00 D), 226 eyes; medium myopes (-6.10 to -10.00 D), 104 eyes; high myopes (-10.10 to -25.00 D), 39 eyes. Follow-up at 12 months was available for 348 eyes (94%). RESULTS: One year after surgery the number of eyes within +/- 1.00 D of emmetropia was 182 (86.7%) for low myopes, 43 (40.5%) for medium myopes, and 12 (30.8%) for high myopes. Values for +/- 0.50 D were low: 142 (67.6%), medium: 29 (29.3%), and high: 9 (23.1%). Three eyes with low myopia (1.4%) and 5 eyes with medium myopia (5.1%) lost 2 or more lines of spectacle-corrected visual acuity. None of the high myopes lost 2 or more lines. Uncorrected visual acuity of 20/20 or better was achieved in 82 eyes (39%) with low myopia; 20/40 or better was achieved in 183 eyes (87.1%). Five eyes (5.1%) of medium myopes achieved 20/20 or better; 52 eyes (52.5%) with medium myopia achieved 20/40 or better. Zero eyes with high myopia achieved 20/20 or better; 11 eyes (28.8%) achieved 20/40 or better. CONCLUSION: Photorefractive keratectomy proved to be an effective method to correct myopia up to -6.00 D. For myopia greater than -6.00 D, good results were achieved in most eyes when myopia was less than -10.00 D, but efficacy and predictability decrease. To avoid systematic undercorrection, slight overcorrection must be attempted with the Aesculap-Meditec MEL 60 excimer laser for the treatment of myopia.     

A multicenter trial of photorefractive keratectomy for residual myopia after previous ocular surgery. Summit Therapeutic Refractive Study Group

PURPOSE: The Summit Therapeutic Refractive Clinical Trial is a nine-center prospective, nonrandomized, self-controlled trial to assess the efficacy, stability, and safety of using a standardized technique of excimer laser photorefractive keratectomy (PRK) to correct residual myopia in eyes with previous refractive surgery or cataract surgery. PATIENTS AND METHODS: Eligible eyes with a mean residual myopia of -3.7 +/- 1.8 diopters (D) (range, -0.63 to -11.00 D) underwent PRK with a 193-nm excimer laser for myopic corrections between -1.50 and -7.50 D. Standardized settings were used for the ablation zone, ablation rate, repetition rate, and fluence. One hundred seven of the first 114 treated eyes were examined 1 year after PRK, with 98% of eyes having had refractive keratotomy and 2% having had cataract surgery. RESULTS: One year postoperatively, the mean manifest spherical equivalent refraction was -0.6 +/- 1.4 D (range, -6.50 to 2.50 D); 63% of eyes were within +/-1.00 D of the attempted correction; and uncorrected visual acuity was 20/40 or better in 74% of eyes. Twenty-nine percent of eyes lost two or more Snellen lines of best-corrected visual acuity, and central corneal haze was moderate or severe in 8% of eyes. CONCLUSIONS: Excimer laser PRK is effective in reducing residual myopia after previous refractive and cataract surgery. However, it is less accurate than PRK in eyes that did not undergo surgery and is more likely to cause a loss of best-corrected visual acuity 1 year after treatment.     

Multizone photorefractive keratectomy for high and very high myopia: long-term results

PURPOSE: To compare 2 year results of multizone excimer laser photorefractive keratectomy (PRK) in eyes with myopia (spherical equivalent [SE]) from 6.00 to 10.00 diopters (D) with those in eyes with myopia from 10.25 to 25.75 D. SETTING: Wellington Hospital and Laser Vision Harley Street, London, England. METHODS: Of the 281 PRK cases with an SE of at least -6.00 D, 59 eyes had a minimum follow-up of 2 years. Twenty-six of these had an SE from -6.00 to -10.00 D and 33, from -10.25 to -25.75 D. The single-pass, multizone technique was used to create ablation zones at 5.0, 5.5, and 6.0 mm. Postoperatively, patients received a minimum of 4 weeks of fluorometholone 0.1%; those exhibiting regression after corticosteroids were discontinued were restarted on a tapering regimen. RESULTS: The refraction stabilized 3 months postoperatively in the -6.00 to -10.00 D group, and the final mean SE refraction was a small undercorrection. Two years postoperatively, 88.5% of eyes had a visual acuity of 20/40 or better, and 77.0% were within +/- 1.00 D of the intended correction. In eyes with myopia greater than 10.00 D, regression continued during the 2 years and refraction did not stabilize. Forty-two percent had an uncorrected acuity of 20/40 or better, and 48.0% were within +/- 1.00 D of the intended correction. The incidence and severity of haze were higher in the group with myopia greater than 10.00 D. The overall incidence of complications was low. CONCLUSION: Two years after multizone PRK, refractive and visual acuity results in eyes with myopia from 6.00 to 10.00 D were good. Results in eyes with myopia of more than 10.00 D were not satisfactory, and refraction had not stabilized.     

Teratomas in infancy and childhood at Tygerberg Hospital, South Africa, 1973 to 1992

PURPOSE: To contribute data regarding results of reoperation with excimer laser for the treatment of residual myopia, and to improve corneal clarity following previous photorefractive keratectomy for 'moderate' (< -9 D) and 'high' (> -9 D) myopia. METHODS: Surface reablations with excimer laser (5 mm treatment diameter) were performed to correct residual myopia and remove subepithelial scars. Refraction, visual acuity, and corneal clarity were recorded with average follow-up of one and two years after reoperation. RESULTS: In 27 eyes with 'moderate' myopia before the first operation, significant improvement was obtained regarding refraction (changed from -2.3 +/- 1.56 D before retreatment to -0.58 +/- 1.31 D after retreatment (p < 10[-3])), and uncorrected visual acuity (improved to > or = 0.8 in 51.8% of the cases). All cases (6 eyes) with corneal scars improved. Six eyes with 'high' myopia showed no improvement of refraction following reoperation. Effects on corneal clarity were mixed in that group. CONCLUSION: We were able to improve the results of photorefractive keratectomy for 'moderate' myopia with a second excimer laser ablation. The risks involved in retreatments of such eyes are small. In 'high' myopia, reablations with a 5 mm treatment zone did not improve the refractive outcome on a long-term basis.     

Photorefractive keratectomy versus laser in situ keratomileusis for moderate to high myopia. A randomized prospective study

OBJECTIVE: This report presents the results of a randomized clinical trial of photorefractive keratectomy (PRK) and laser-assisted in situ keratomileusis (LASIK). DESIGN: A randomized, prospective multicenter clinical trial. PARTICIPANTS: A total of 220 eyes of 220 patients entered the study cohort: 105 randomized to PRK and 115 to LASIK. The mean preoperative manifest refraction spherical equivalent was -9.23 diopters (D) in the PRK group and -9.30 D in the LASIK group. INTERVENTION: All patients received a one-pass, multizone excimer laser ablation as part of either a PRK or LASIK procedure using the Summit Apex excimer laser. Attempted corrections ranged from 6.00 to 15.00 D. MAIN OUTCOME MEASURES: Data on uncorrected and spectacle-corrected visual acuity, predictability,and stability of refraction, corneal haze, and flap complications were analyzed. Patients were observed for up to 6 months. RESULTS: One day after surgery, 0 (0.0%) and 3 (4.5%) eyes in the PRK group saw 20/20 and 20/40 or better uncorrected, respectively, while 7 (10%) and 48 (68.6%) eyes in the LASIK group saw 20/20 and 20/40 or better, respectively. At 6 months after PRK, 13 (19.1%) and 45 (66.2%) eyes saw 20/20 and 20/40 or better, respectively, while after LASIK, 16 (26.2%) and 34 (55.7%) eyes saw 20/20 and 20/40 or better, respectively (odds ratio = 0.56 for likelihood of uncorrected visual acuity < 20/40 for PRK vs. LASIK, 95% confidence interval [CI] = 0.31-1.19). After PRK, 39 eyes (57.4%) were within 1.0 D of attempted correction compared with 24 eyes (40.7%) in the LASIK group (odds ratio = 0.50 for likelihood fo undercorrection 1.0 D for PRK vs. LASIK, 95% CI = 0.24-1.04); however, the standard deviation of the predictability was similar between groups: 1.01 D for PRK and 1.22 D for LASIK. From months 1 to 6, there was an average regression of 0.89 D in the PRK group and 0.55 D in the LASIK group. After PRK, eight eyes (11.8%) had a decrease in spectacle-corrected visual acuity of two Snellen lines or more; after LASIK, two eyes (3.2%) had a decrease of two lines or more (odds ratio = 3.89 for risk of loss of spectacle-corrected visual acuity for PRK vs. LASIK, 95% CI = 0.71-21.30). Only two eyes had postoperative spectacle-corrected visual acuity less than 20/32, however. CONCLUSIONS: Although improvement in uncorrected visual acuity is more rapid in LASIK than in PRK, efficacy outcomes in the longer term generally are similar between the two procedures. There is a greater tendency toward undercorrection in LASIK eyes using the specific laser and nomogram in this study, but the scatter in achieved versus attempted correction is similar, suggesting little difference in the accuracy of the two procedures. A suggestion of decreased propensity for loss of spectacle-corrected visual acuity in LASIK eyes requires further investigation.     

Correlation of pituitary hormones in serum of male patients with fertility problems

The advent of the excimer laser has brought about the potential for improved vision in many individuals with myopia and astigmatism. However, photoastigmatic refractive keratectomy (PARK) remains a matter of controversy. The purpose of our study was to determine the predictability of VISX 20/20 excimer laser photorefractive keratectomy in the treatment of myopic astigmatism. PATIENTS AND METHODS: Our study comprised 31 eyes of 22 patients with myopic astigmatism. All patients underwent treatment with a VISX 20/20 excimer laser and were followed up for 6 months. Complete 12-month follow-up data were available from 18 eyes. Park was performed in eyes with myopia between -1.5 and -10.0 D and with astigmatism between -0.5 and -5.5 D. Thus, the corresponding spherical equivalent ranged from -1.75 to -10.5 D. RESULTS: Six months postoperatively, 21/31 (62%) eyes were within +/- 1.0 D of the target refraction and 13/31 (42%) within +/- 0.5 D of the target refraction. In 13 of 15 eyes (87%) with myopia less than -6.0 D, an uncorrected visual acuity of at least 0.8 was noted. In eyes with myopia greater than -6.0 D, 9/16 (56%) showed an uncorrected visual acuity of at least 0.5. Six months after PARK, an increase of one line on the Snellen Visual Acuity Chart was observed in 8/31 (26%) and an increase of two lines was noted in eyes 3/31 (10%). One of 31 eyes (3%) showed an increase of three lines. A decrease in visual acuity of 1 line on the Snellen Visual Acuity Chart was found in 4/31 (13%), and in 3/31 eyes (10%) a decrease of 2-4 lines was noted. Overall, we observed a statistically significant reduction of astigmatism from 1.93 +/- 1.43 D to 0.93 +/- 0.63 D. Reduction of corneal astigmatism less than -1.25 D was not statistically significant. In eyes with astigmatism ranging from -1.25 to -2.5 D or greater than -2.75 D, a significant reduction of the mean astigmatism was noted. The postoperative regression of astigmatic correction was low. However, an axis shift of more than 15 degrees was found in 42%/35% of eyes by subjective refraction (miosis/cycloplegia) and in 33% in corneal topography. No central islands were noted. CONCLUSION: Photoastigmatic refractive keratectomy (PARK) constitutes a potential means of correcting myopic astigmatism. In eyes with astigmatism greater than -1.0 D a significant reduction of 60% of the mean astigmatism was noted. However, the considerable proportion of eyes with a postoperative axis shift greater than 15 degrees and a decrease in visual acuity of two or more lines indicates that further research is needed on excimer laser surgery to improve the reliability and safety.     

Amniotic fluid for screening of lysosomal storage diseases presenting in utero (mainly as non-immune hydrops fetalis)

PURPOSE: We studied the efficacy and safety of a recent technique of keratomileusis for myopia, excimer laser in situ keratomileusis. METHODS: We studied retrospectively 88 eyes of 63 patients who received excimer laser in situ keratomileusis with the Chiron Automated Corneal Shaper and the Summit OmniMed laser under a hinged corneal flap without sutures. RESULTS: Mean follow-up was 5.2 months. Mean spherical equivalent of the manifest refraction before surgery was -8.24 diopters (range, -2.00 to -20.00 diopters). Mean spherical equivalent refraction after surgery was +0.22 +/- 1.42 diopters. Of 40 eyes with a baseline refraction from -2.00 to -6.00 diopters, 25 eyes (63%) had refraction within +/- 0.50 diopter of emmetropia, and 37 eyes (93%) had refraction within +/- 1.00 diopter. In eyes with baseline refraction of -6.12 to -12.00 diopters, postoperative refraction was within +/- 1.00 diopter in 19 (65%) of 29 eyes. In eyes with baseline refraction of -12.10 to -20.00 diopters, postoperative refraction was +/- 1.00 diopter in eight (43%) of 19 eyes. Overall, 64 (72.8%) of 88 eyes had a refraction within +/- 1.00 diopter after surgery. Between three weeks and five months after surgery the change in the mean spherical equivalent refraction was -0.61 diopter in the myopic direction. Uncorrected visual acuity after surgery was 20/20 or better in 31 eyes (36%) and 20/40 or better in 61 eyes (71%). Three eyes (3.6%) lost two lines or more of spectacle-corrected visual acuity, two from progressive myopic maculopathy and one from irregular astigmatism. No eyes had vision-threatening complications. CONCLUSION: Excimer laser in situ keratomileusis under a corneal flap can be an effective method of reducing myopia between -2.00 and -20.00 diopters, with minimal complications. Current surgical algorithms need modification to improve predictability of outcome. Stability of refraction after surgery requires further study.     

Photorefractive keratectomy for hyperopia and aphakia with a scanning spot excimer laser

OBJECTIVE: To study the safety, efficacy, predictability, and stability of photorefractive keratectomy (PRK) for hyperopia and aphakia. METHODS: Fifteen eyes of 15 patients (mean age, 33 +/- 5.95 yrs) were enrolled in the study and divided into three groups. The first group was comprised of six eyes that had hyperopia ranging from +1.75 to +4.75 D; the second group had seven hyperopic eyes ranging from +5.00 to +9.75 D; the third group included two eyes of two aphakic patients. All eyes had PRK with a 193 nm argon fluoride excimer laser (Chiron-Technolas, Keracor 116) with a 10 Hz repetition rate and a fluence of 120 mJ/cm2. The total follow-up time in all eyes was 12 months. RESULTS: In the lower hyperopia group, 0% eyes were within +/- 0.50 D and 66% (N = 4) of eyes were within +/- 1.00 D of emmetropia with the other two eyes between +1.00 and +2.00 D at 1 year after PRK. In the higher hyperopia group, all eyes had at least +3.00 D of hyperopia at 1 year. In the aphakic group, both eyes achieved less than 50% of the target correction of +10.00 D at 1 year. Final uncorrected visual acuity ranged from 20/20 to 20/30 in the lower hyperopia group, 20/30 to 20/50 in the higher hyperopia group, and count fingers in the aphakic group. CONCLUSIONS: PRK is a relatively safe, stable, and effective procedure with reasonably good predictability for eyes with less than +5.00 D of baseline hyperopia, and poor predictability for eyes with more than +5.00 D of baseline hyperopia. PRK is ineffective in the correction of aphakia.     

Refractive results after photorefractive excimer laser treatment in mild myopic and in mild hyperopic eyes

Evaluation of 12-month results of photorefractive keratectomies (PRK) performed in low myopic (0 to -6.0 D) and low hyperopic (0 to +6.0 D) eyes. Myopic and hyperopic PRK treatments with the Aesculap Meditec MEL 60 ArF excimer laser. Prospective study, 30 eyes per group. The change in best corrected visual acuity (VA), refraction required, uncorrected VA and the postoperative haze were compared at the 12th postoperative month. The average preoperative correction in the low myopic eyes (Group I) was -4.65 +/- 1.24 D, which decreased to -0.17 +/- 0.56 D during the follow-up. In mild hyperopic eyes (Group II) the preoperative refraction was +3.9 +/- 0.93 D and decreased to +1.23 +/- 1.59 D post-PRK. Comparing the pre- and postoperative average best corrected VA values, there was no statistical change in either group. In the low myopic group all eyes had a 20/40 or better uncorrected VA, in hyperopic eyes 11 had a VA of 20/40 or better, four had a worse uncorrected VA. In Group I, 86.6% of the eyes were within +/-1.0 D of the intended refraction at 12 months postoperatively. In Group II, 46.7% of the eyes were within +/-1.0 D of final refraction. There were no intergroup differences in subjective complaints, reepithelization and average postoperative haze. Both methods are able to alter the refractive power of the cornea toward emmetropia. The predictability of the method was to be found higher in cases of mild myopia than in mild hyperopia. The upper limit of myopia is above -6.0 D, but in hyperopia, with the present technical facilities, good postoperative results can be obtained only as far as +4.25 D of preoperative refractive error.     

Analysis of prostate tissue DNA for the presence of human papillomavirus by polymerase chain reaction, cloning, and automated sequencing

BACKGROUND AND OBJECTIVE: As photorefractive keratectomy (PRK) becomes more widely used, the incidence of repeated PRK increases. The present study was conducted to evaluate results of repeated PRK in view of the meager data on this topic. PATIENTS AND METHODS: In this retrospective study, the authors reviewed the records of 1028 eyes that had undergone PRK, and analyzed the results of 66 eyes that required a second PRK for undercorrection according to baseline refraction. RESULTS: A second PRK was performed in 6.3%, 13.7%, and 10.1% of low, moderate, and high myopes, respectively. The mean refraction 1 year after repeated PRK was similar in both myopic groups: less than -1.00 D. Of the low myopes, 87.50% had residual refraction within 1 D after 1 year. Of the moderate myopes, 88.23% had residual refraction within 1 D after 1 year. All of the low myopes achieved uncorrected visual acuity (VA) of 20/25 or better 1 year after repeated PRK, compared with 58.82% of the moderate myopes. Loss of best-corrected VA never exceeded two lines. CONCLUSION: The overall results of PRK appear to be satisfactory.     

Results of excimer laser photorefractive keratectomy for the correction of myopia

PURPOSE: This report summarizes the authors' 3-year experience with excimer laser photorefractive keratectomy on 240 eyes of 161 patients. METHODS: With constant laser emission parameters, nitrogen flow across the cornea was used on 79 eyes, whereas 161 eyes had no nitrogen flow. Of the 240 eyes, 74 were operated on without suction ring fixation. Postoperative pain management included patching and oral analgesics in 77 eyes and the use of topical diclofenac or ketorolac and a therapeutic soft contact lens in 163 eyes. Follow-up ranged from 1 month (206 eyes) to 36 months (10 eyes). RESULTS: At 3 months, 88% (144 eyes) had uncorrected visual acuity of 20/40 or better; 86% (151 eyes) had corrected visual acuity to within +/- 1 diopter of intended correction, and 10% (17 eyes) lost two or more lines of best-corrected visual acuity. At 12 months, 89% (122 eyes) achieved uncorrected visual acuity of 20/40 or better, 79% (115 eyes) had corrected visual acuity to within +/- 1 diopter of intended correction, and 4% (6 eyes) lost two or more lines of best-corrected visual acuity. At 24 months, 92% (44 of 48 eyes) had uncorrected visual acuity of 20/40 or better, 86% (44 of 51 eyes) had corrected visual acuity to within +/- 1 diopter of intended correction, and 5% (2 eyes) lost two or more lines of best-corrected visual acuity. At 36 months, 90% (9 eyes) achieved an uncorrected visual acuity of 20/40 or better, 90% (9 eyes) had corrected visual acuity to within +/- 1 diopter of intended correction, and no eyes lost two or more lines of best-corrected visual acuity. CONCLUSIONS: The results obtained with one procedure are within accepted standards of accuracy for refractive surgery, and there is the potential for refinement of the final optical correction. Complication rates are low and are not vision threatening. They included increased intraocular pressure, epithelial "map dot" changes, and recurrent corneal erosion syndrome, "central islands," and others. Photorefractive keratectomy appears to be a safe procedure over the short and medium term.     

Correction of low-grade and mild myopia using Schwind Excimer laser

PURPOSE: To examine the results of Excimer laser photorefractive keratectomy on myopic eyes. To demonstrate the efficacy, safety, predictability and stability of the Schwind Keratom laser. METHODS: Two hundred and fifty three patients were operated, with myopia from -0.75 to -8 D and cylinder of less than 1.50 D. Ablation zone diameters were from 5.3 mm to 6.5 m. The follow-up was one year. RESULTS: One year after the operation, 92% of myopic eyes have uncorrected visual acuity above 20/40, 90% have best corrected visual acuity at least equal to that evaluated before treatment, 94% were within (1 D without correction. Between 6 months and one year, the spherical equivalent varied in only 4% the patients. CONCLUSIONS: The results with the Schwind Keratom laser are excellent and at least comparable with the other lasers. The best results are obtained with low myopia. At the end of this study, the Schwind Keratom laser was certified in France.     

Teledermatology and in-person examinations: a comparison of patient and physician perceptions and diagnostic agreement

PURPOSE: The aim of this study was to assess the outcome of reoperation following photorefractive keratectomy related to different techniques. MATERIAL AND METHODS: 265 retreated eyes were divided into 5 groups; low to moderate myopia, high myopia, enlargement, abrasion, and non-compliance. The low to moderate group was further subdivided into 5 categories based on the surgical approach of the reoperation. Outcomes were compared at 12 months after reoperation. RESULTS: There was no statistically significant difference in the median refraction prior to initial PRK, before reoperation, and after reoperation between the 5 categories 66%, of all reoperated patients achieved an uncorrected visual acuity of 0.5 or better after 12 months. 72% had a postoperative refraction between +/- 1 diopter. The other 4 groups were not statistically analyzed due to the wide variety of patients included and non-compliance. CONCLUSION: In low to moderate myopes, approximately 97% achieve uncorrected visual acuity of 0.5 or better following PRK, including one reoperation.     

Photorefractive keratectomy for hyperopia using an erodible disc and axicon lens: 2-year results

BACKGROUND: This paper presents the results over a 2-year follow-up of the first human trial of photorefractive keratectomy (PRK) for correction of hyperopia using an erodible disc excimer laser delivery system (Summit) coupled to an axicon lens. METHODS: We treated 25 eyes of 21 patients for a mean correction of +3.38 +/- 0.97 D (range, +1.00 to +4.00 D). The hyperopic correction was made using an erodible disc inserted on the laser optical pathway; an axicon lens was then used to create a blend transition zone. Eyes were evaluated at 1, 3, 6, and 12 months after surgery. For a smaller series of 11 eyes, we also present 24-month results. RESULTS: Mean refractive error 1 month after treatment (25 eyes) was -2.35 +/- 1.55 D (range, +1.00 to -6.50 D). Eight eyes (32%) had a spectacle-corrected visual acuity loss greater than 1 line. Twelve months after treatment, mean spherical equivalent refraction was -0.47 +/- 0.80 D (range, +1.25 to -2.25 D). Nineteen eyes showed an improvement (range, 3 to 8 lines) in uncorrected distance visual acuity and 23 showed improvement in uncorrected vision at reading distance (1 to 7 lines). CONCLUSION: This technique proved effective in reducing hyperopia, but predictability must be demonstrated in a larger treatment group. Safety was confirmed by the absence of delayed reepithelialization and the absence of spectacle-corrected visual acuity loss greater than 1 line at 1 year after surgery.     

Laser thermal keratoplasty for the treatment of photorefractive keratectomy overcorrections: a 1-year follow-up

OBJECTIVE: To evaluate the results of holmium:YAG laser thermal keratoplasty (LTK) treatment for overcorrection of myopia after a photorefractive keratectomy (PRK) treatment. PARTICIPANTS: Thirty-six eyes (33 patients) were treated with a nontouch holmium:YAG laser (Sunrise Technologies, Model LTK, Freemont, CA) because of hyperopia (mean +/- standard deviation of +2.06 diopter [D] +/- 0.75, ranging from +1.0 to +3.5 D) following a PRK treatment. A control LTK group treated for primary hyperopia, who had preoperative refraction values not statistically different from the PRK + LTK group, was used for comparison. INTERVENTION: The number of spots applied varied from 8 to 24, and the energy used was 200 to 240 mJ. A maximum of three rings of four to eight spots were placed between 6 and 8 mm from the visual axis. RESULTS: Twelve months after the LTK retreatment for PRK patients, mean refraction was +1.14 D +/- 1.09. Regression from 1 to 12 months was 0.5 D +/- 1.1. At 12 months, 50% of eyes were within 1 D of emmetropia; 93% of eyes had uncorrected visual acuity (UCVA) of 20/40 or better; and 24% of eyes had UCVA of 20/20 or better. Refraction was not stable for 11 eyes (34%) that regained original sphere values or higher. Best-corrected visual acuity was not affected, and haze was not increased nor decreased by the procedure. CONCLUSIONS: Twelve months after an LTK retreatment for an initial PRK, two thirds of the retreated eyes did not need further retreatments. However, clinical data showed that LTK should be kept for +1 to +2 D of hyperopia for PRK overcorrection retreatments.     

Comparison of photorefractive keratectomy with excimer laser in situ keratomileusis in correcting low myopia (from -2.00 to -5.50 diopters). A randomized study

OBJECTIVE: To compare laser in situ keratomileusis (LASIK) with photorefractive keratectomy (PRK) in the correction of myopia from -2.00 to -5.50 diopters. DESIGN: Prospective, randomized, paired clinical trial. PARTICIPANTS: Fifty-two eyes of 26 myopic patients were enrolled in the study. INTERVENTION: Each patient received PRK on one eye (PRK eye) and LASIK on the other (LASIK eye); the procedure assigned to each eye, and the sequence of surgeries for each patient was randomized. MAIN OUTCOME MEASURES: Slit-lamp microscopy, manifest refraction, uncorrected and spectacle-corrected visual acuity, and videokeratography were done before operation, and 2 weeks, 6 weeks, 3 months, 6 months, and 12 months after operation. Patient satisfaction and preference were assessed by a subjective questionnaire. RESULTS: All LASIK eyes had fast, painless recovery. At 1 year, 24 patients (92.3%) were examined, the mean spherical equivalent refraction was -0.08 +/- 0.38 diopter in the PRK eyes and -0.14 +/- 0.31 diopter in the LASIK eyes, and the uncorrected visual acuity was 20/20 or better in 15 PRK eyes (62.5%) and 19 LASIK eyes (79.2%); no eye lost 2 or more Snellen lines of spectacle-corrected visual acuity. Both procedures were stable throughout the first year. One PRK eye developed dense subepithelial corneal haze. The strongest correlate to spectacle-corrected visual acuity after the two procedures was the coefficient of variation of corneal power over the pupil. Nineteen patients (79.2%) preferred the LASIK procedure because of the fast, painless recovery. CONCLUSIONS: In the current study, PRK and LASIK were found to be similarly effective, predictable, stable, and reasonably safe for the correction of myopia between -2.00 and -5.50 diopters. Laser in situ keratomileusis has the advantage of fast, painless recovery. Patients prefer LASIK.     

Results of photorefractive keratectomy for myopia with the technolas keracor 116 excimer laser

BACKGROUND: The refractive results of first consecutive 157 myopic eyes undergoing photorefractive keratectomy with the Technolas Keracor 116 excimer laser are presented with a 6-month follow up. METHODS: Preoperative refractive errors (spherical equivalent) ranged between -1.75 diopters (D) and -20.00 D (mean: -7.19 +/- 3.73). A single ablation zone ranging from 4.5 mm to 6 mm was used. In all eyes except for those with myopia over -15 D, emmetropia was a goal. Postoperatively patients used fluoromethalone drops for 1 month. RESULTS: Treated eyes were divided into four groups based on preoperative myopia. Group 1 contained 15 eyes with myopia less than -3 D (93% were within +/- 1 D postoperatively). In Group 2 there were 53 eyes with preoperative myopia between -3.25 D and -6.00 D (64.1% were within +/- 1 D postoperatively). Group 3 consisted of 53 eyes with preoperative myopia between -6.25 D and -10.00 D (41.5% were within +/- D postoperatively). Group 4 contained 36 eyes with myopia over -10.00 D (13.8% were within +/- 1 D of attempted correction and 11.1% were within +/- 1 D postoperatively). CONCLUSIONS: Our study suggests that excimer laser photorefractive keratectomy using a 4.5 to 6.0 mm ablation zone effectively reduces myopia; however, predictability decreases as the attempted correction increases.     

Treatment of myopic astigmatism with the Summit Apex Plus excimer laser

PURPOSE: To assess the results of surface sequential toric photorefractive keratectomy (PRK) with the Summit Apex Plus excimer laser using an erodible mask. METHODS: A prospective study was performed on consecutive eyes having surface sequential toric PRK over a 4 month treatment period. Attempted astigmatism correction varied from 70 to 100%, depending on the power and axis of the cylinder. The myopic correction was adjusted so the combined treatment aim was emmetropia. Refraction, manual keratometry, corneal haze, and visual acuity data from preoperative and follow-up visits over 12 months were divided into various groups based on the preoperative refraction and analyzed. RESULTS: Fifty-nine eyes from 48 patients had sequential toric PRK. Preoperatively, the mean spherical equivalent at glasses plane (SEGP) was -4.88 diopters (D) +/- 3.20 (SD) and the mean refractive cylinder, 2.02 +/- 1.04 D. The mean attempted cylinder correction was 1.87 D. At 12 months the mean SEGP was -0.02 +/- 0.67 D, which was not statistically significant from plano. The mean refractive cylinder was 0.84 +/- 0.84 D, which was statistically significantly different from zero cylinder power. There was a statistically significant correlation between the preoperative and the 12 month postoperative refractive cylinder powers. At 12 months, 34 of 43 eyes (79.1%) had an uncorrected visual acuity of 6/12 or better. While 2 eyes in one patient (4.7%) lost two lines of best corrected visual acuity, with a final acuity of 6/12 in each, no patient lost more than two lines. CONCLUSION: The manifest refraction cylinder power is not fully corrected with the current treatment algorithms; however, surface sequential toric PRK using an erodible mask is capable of treating compound myopic astigmatism with moderate success.     

Laser in situ keratomileusis for moderate and high myopia and myopic astigmatism

OBJECTIVE: This study evaluated the predictability, stability, and safety of laser in situ keratomileusis (LASIK) in myopia and myopic astigmatism. DESIGN: The study design was a prospective, unmasked, nonrandomized clinical trial. PARTICIPANTS: Participating were 25 patients with myopia (37 eyes) with astigmatism of less than 1.00 diopter (D), divided into 3 subgroups (-5.00 to -9.90 D, 8 eyes; -10.00 to -14.90 D, 10 eyes; -15.00 to -29.00 D, 19 eyes), and 37 patients with myopia (56 eyes) with corneal astigmatism of 1.00 to 4.50 D, divided into 3 subgroups (-5.00 to -9.90 D, 12 eyes; -10.00 to -14.90 D, 24 eyes; -15.00 to -29.00 D, 20 eyes). INTERVENTION: LASIK was performed using the Automatic Corneal Shaper and the Keracor 116 excimer laser. MAIN OUTCOME MEASURES: Visual acuity, manifest refraction, central corneal islands, ablation decentration, and patient satisfaction were measured. RESULTS: At 12 months, predictability, regression between 1 and 12 months, uncorrected visual acuity (UCVA), loss of two or more lines of corrected visual acuity, and patient satisfaction of the spherical (toric) groups are reported. Subgroups -5.00 to -9.90 D: 100% (75%) +1.00 D; regression less than or equal to 1.00 D in 100% (91.7%); UCVA greater than or equal to 20/40 in 87.5% (70%); none lost two or more lines; 100% (84%) highly satisfied. Subgroups -10.00 to -14.90 D: 60% (78.3%) +/-1.00 D; regression less than or equal to 1.00 D in 100% (87%); UCVA greater than or equal to 20/40 in 77.8% (86.4%); 10% (4.3%) lost two lines; 90% (91%) highly satisfied. Subgroups -15.00 to -29.00 D: 38.9% (21.4%) +/-1.00 D; regression less than or equal to 1.00 D in 72.2% (64.3%); UCVA greater than or equal to 20/40 in 33.3% (40%); 5.6% (7.1%) lost two lines; 78% (50%) highly satisfied. Differences of predictability and change of manifest refraction between subgroups of -5.00 to -9.90 D and -15.00 to -29.00 D were statistically significant. Central islands (decentrations) were observed in 17% (5.6%) of eyes of the spherical and in 16% (4.1%) of the toric group. Overall, the corneal interface was visible in 8.2%. CONCLUSIONS: The LASIK method used in this study showed stability of manifest refraction and adequate uncorrected central visual acuity in a large percentage of patients with myopia up to -15.00 D. Corneal stability was not as uniform. Central corneal islands were observed in a sizable minority of patients despite pretreatment. For myopia greater than 15.00 D, accuracy and patient satisfaction were sufficiently poor to advise against using the authors' treatment technique in these groups. Visually significant microkeratome and laser-related problems were noted in a smaller percentage of patients. Patients with astigmatism correction were less pleased with results than were patients who received spherical corrections.